Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. covers the month of April 2024. The report serves to notify shareholders of the convening of the Annual General Meeting scheduled for April 25, 2024, and incorporates related meeting materials by reference.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses solely on corporate governance activities related to the upcoming Annual General Meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It references attached exhibits (Convening Notice and Voting Proxy) which may contain additional details, but those contents are not included in the provided text.
Key Facts for Investors
- Meeting Date: The Annual General Meeting is scheduled for April 25, 2024.
- Document Purpose: This filing incorporates the Convening Notice, Agenda, Explanatory Notes, and Voting Proxy by reference.
- Financial Data: No financial results or metrics are disclosed in this specific filing.
- Signatory: The report was signed by Niels Riedemann, Chief Executive Officer, on April 4, 2024.